Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Australian Prescriber
|
December 6, 2023
Chimeric antigen receptor T-cell therapy
Cale Burge, Vinay Vanguru, Phoebe Joy Ho
Asia-Pacific Journal of Clinical Oncology
|
December 23, 2022
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy
Sarah Heynemann, Vinay Vanguru, Stephen Adelstein, et al.
Pathology
|
December 22, 2021
Red cell transfusion in alloimmunised allogeneic stem cell transplant patients
Jacinta Perram, Vinay Vanguru, Lynette Ackerman, et al.
Medical Mycology Case Reports
|
March 1, 2024
Haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in an immunocompetent patient
Mallory Morton, Vinay Vanguru, Joo-Shik Shin, et al.
BMC Nephrology
|
August 14, 2020
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report
Jack E Heron, Mark Bloch, Vinay Vanguru, et al.
Pathology
|
November 22, 2023
Flow cytometric immunophenotype of CAR T-cells in pleural fluid and differences with peripheral blood CAR T-cells in a patient with large B-cell lymphoma
Eric Wenlong Li, Esther Aklilu, Alison Potter, et al.
Transplantation and Cellular Therapy
|
May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone Prophylaxis
Gemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
Frontiers in Oncology
|
September 4, 2025
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimization
Phoebe Joy Ho, Vinay Vanguru, Cale S Burge, et al.
European Journal of Haematology
|
July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies
Eric Wenlong Li, Esther Jones, Christian Bryant, et al.
Transplantation and Cellular Therapy
|
January 8, 2025
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies
Edward Abadir, Rebecca Wayte, Wenlong Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Australian Prescriber
|
December 6, 2023
Chimeric antigen receptor T-cell therapy
Cale Burge, Vinay Vanguru, Phoebe Joy Ho
Asia-Pacific Journal of Clinical Oncology
|
December 23, 2022
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy
Sarah Heynemann, Vinay Vanguru, Stephen Adelstein, et al.
Pathology
|
December 22, 2021
Red cell transfusion in alloimmunised allogeneic stem cell transplant patients
Jacinta Perram, Vinay Vanguru, Lynette Ackerman, et al.
Medical Mycology Case Reports
|
March 1, 2024
Haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in an immunocompetent patient
Mallory Morton, Vinay Vanguru, Joo-Shik Shin, et al.
BMC Nephrology
|
August 14, 2020
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report
Jack E Heron, Mark Bloch, Vinay Vanguru, et al.
Pathology
|
November 22, 2023
Flow cytometric immunophenotype of CAR T-cells in pleural fluid and differences with peripheral blood CAR T-cells in a patient with large B-cell lymphoma
Eric Wenlong Li, Esther Aklilu, Alison Potter, et al.
Transplantation and Cellular Therapy
|
May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone Prophylaxis
Gemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
Frontiers in Oncology
|
September 4, 2025
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimization
Phoebe Joy Ho, Vinay Vanguru, Cale S Burge, et al.
European Journal of Haematology
|
July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies
Eric Wenlong Li, Esther Jones, Christian Bryant, et al.
Transplantation and Cellular Therapy
|
January 8, 2025
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies
Edward Abadir, Rebecca Wayte, Wenlong Li, et al.
Page
of 2